HRT Financial’s Metagenomi Therapeutics MGX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGX
HRT Financial's MGX Position: Q3 2026 in Review
HRT Financial opened a new position in Metagenomi Therapeutics (MGX) in Q3 2026: 52,288 shares worth $55K. The stake represents ﹤0.01% of the portfolio and ranks #4301 among its holdings. This is a return to the name: HRT Financial previously reported a position in MGX as recently as Q1 2026.
HRT Financial first reported a position in MGX in Q1 2024 and has held it in 6 quarters since. The position peaked at $332K in Q1 2024. 44 funds tracked by Wall St. Rank hold MGX as of Q3 2026.
- HRT Financial held 52,288 shares of Metagenomi Therapeutics worth $55K as of Q3 2026.
- Metagenomi Therapeutics was a new HRT Financial position in Q3 2026.
- Metagenomi Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4301 holding.
- HRT Financial first reported a position in Metagenomi Therapeutics in Q1 2024 and has held it in 6 quarters since.
- HRT Financial's Metagenomi Therapeutics position peaked at $332K in Q1 2024.
- 44 funds tracked by Wall St. Rank held Metagenomi Therapeutics as of Q3 2026.
Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.